Serum biomarkers predict ankylosing spondylitis progression
from Medscape Medical News
New research has shown for the first time that serum biomarkers can predict progression of ankylosing spondylitis in patients already at high risk for progression, Joachim Sieper, M.D., Ph.D., said at the European League Against Rheumatism Congress 2012. Using the biomarkers, it might be possible to identify patients who will benefit from early intervention, specifically continuous treatment with nonsteroidal anti-inflammatory drugs, he said.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063